Intramuscular administration of robenacoxib in Caribbean flamingos (Phoenicopterus ruber) results in rapid absorption and a short plasma half-life
Year: 2025
Type: article
Abstract: Objective: To determine the pharmacokinetics of robenacoxib after a single IM dose (2 mg/kg) in Caribbean flamingos (Phoenicopterus ruber). Methods: In the spring of 2025, following a pilot study to determine appropriate dosage, clinically healthy Caribbean flamingos under human care at a zoological institution received a single IM dose of robenacoxib (2 mg/kg) in the left pectoral muscle. Blood samples were collected under manual restraint using a sparse-sampling protocol, where each individual was sampled twice. Samples were collected from the right jugular vein at 15 and 30 minutes and 1, 2, 4, and 8 hours after drug administration. Plasma concentrations were determined using HPLC-MS. A naïve pooled approach was used for pharmacokinetic analysis. Results: 12 flamingos were included in this study. A maximal plasma concentration of 3.51 µg/mL (range, 0.083 to 4.83 µg/mL) was observed at 15 minutes after robenacoxib administration. The plasma terminal half-life was 1.10 hours. Conclusions: IM administration of robenacoxib (2 mg/kg) in Caribbean flamingos results in rapid absorption, with high plasma concentrations reached at 15 minutes, and has a short plasma terminal half-life. Clinical Relevance: A 2-mg/kg IM dose of robenacoxib in Caribbean flamingos results in maximum plasma concentrations above those considered therapeutic in domestic species with no adverse effects of administration.
Institutions: Indianapolis Zoo, University of Tennessee at Knoxville
Language: English
Subfield: Small Animals
Field: Veterinary
Domain: Health Sciences
Open Access status: diamond
OpenAlex ID: W4416485228
FWCI:
Cites:
Cited by:
Related to: